1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specimen Validity Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Laboratory Testing
1.2.3 Rapid/POC Testing
1.3 Market by Application
1.3.1 Global Specimen Validity Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Workplaces
1.3.3 Drug Screening Laboratories
1.3.4 Criminal Justice and Law Enforcement Agencies
1.3.5 Pain Management Centers
1.3.6 Drug Rehabilitation Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Specimen Validity Testing Market Perspective (2017-2028)
2.2 Specimen Validity Testing Growth Trends by Region
2.2.1 Specimen Validity Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Specimen Validity Testing Historic Market Size by Region (2017-2022)
2.2.3 Specimen Validity Testing Forecasted Market Size by Region (2023-2028)
2.3 Specimen Validity Testing Market Dynamics
2.3.1 Specimen Validity Testing Industry Trends
2.3.2 Specimen Validity Testing Market Drivers
2.3.3 Specimen Validity Testing Market Challenges
2.3.4 Specimen Validity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specimen Validity Testing Players by Revenue
3.1.1 Global Top Specimen Validity Testing Players by Revenue (2017-2022)
3.1.2 Global Specimen Validity Testing Revenue Market Share by Players (2017-2022)
3.2 Global Specimen Validity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Specimen Validity Testing Revenue
3.4 Global Specimen Validity Testing Market Concentration Ratio
3.4.1 Global Specimen Validity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specimen Validity Testing Revenue in 2021
3.5 Specimen Validity Testing Key Players Head office and Area Served
3.6 Key Players Specimen Validity Testing Product Solution and Service
3.7 Date of Enter into Specimen Validity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Specimen Validity Testing Breakdown Data by Type
4.1 Global Specimen Validity Testing Historic Market Size by Type (2017-2022)
4.2 Global Specimen Validity Testing Forecasted Market Size by Type (2023-2028)
5 Specimen Validity Testing Breakdown Data by Application
5.1 Global Specimen Validity Testing Historic Market Size by Application (2017-2022)
5.2 Global Specimen Validity Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Specimen Validity Testing Market Size (2017-2028)
6.2 North America Specimen Validity Testing Market Size by Country (2017-2022)
6.3 North America Specimen Validity Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Specimen Validity Testing Market Size (2017-2028)
7.2 Europe Specimen Validity Testing Market Size by Country (2017-2022)
7.3 Europe Specimen Validity Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Specimen Validity Testing Market Size (2017-2028)
8.2 Asia-Pacific Specimen Validity Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Specimen Validity Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Specimen Validity Testing Market Size (2017-2028)
9.2 Latin America Specimen Validity Testing Market Size by Country (2017-2022)
9.3 Latin America Specimen Validity Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Specimen Validity Testing Market Size (2017-2028)
10.2 Middle East & Africa Specimen Validity Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Specimen Validity Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher (US)
11.1.1 Thermo Fisher (US) Company Detail
11.1.2 Thermo Fisher (US) Business Overview
11.1.3 Thermo Fisher (US) Specimen Validity Testing Introduction
11.1.4 Thermo Fisher (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.1.5 Thermo Fisher (US) Recent Development
11.2 Sciteck. (US)
11.2.1 Sciteck. (US) Company Detail
11.2.2 Sciteck. (US) Business Overview
11.2.3 Sciteck. (US) Specimen Validity Testing Introduction
11.2.4 Sciteck. (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.2.5 Sciteck. (US) Recent Development
11.3 American Bio Medica Corporation (ABMC)
11.3.1 American Bio Medica Corporation (ABMC) Company Detail
11.3.2 American Bio Medica Corporation (ABMC) Business Overview
11.3.3 American Bio Medica Corporation (ABMC) Specimen Validity Testing Introduction
11.3.4 American Bio Medica Corporation (ABMC) Revenue in Specimen Validity Testing Business (2017-2022)
11.3.5 American Bio Medica Corporation (ABMC) Recent Development
11.4 Alere (US)
11.4.1 Alere (US) Company Detail
11.4.2 Alere (US) Business Overview
11.4.3 Alere (US) Specimen Validity Testing Introduction
11.4.4 Alere (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.4.5 Alere (US) Recent Development
11.5 Express Diagnostics (US)
11.5.1 Express Diagnostics (US) Company Detail
11.5.2 Express Diagnostics (US) Business Overview
11.5.3 Express Diagnostics (US) Specimen Validity Testing Introduction
11.5.4 Express Diagnostics (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.5.5 Express Diagnostics (US) Recent Development
11.6 Premier Biotech (US)
11.6.1 Premier Biotech (US) Company Detail
11.6.2 Premier Biotech (US) Business Overview
11.6.3 Premier Biotech (US) Specimen Validity Testing Introduction
11.6.4 Premier Biotech (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.6.5 Premier Biotech (US) Recent Development
11.7 LabCorp (US)
11.7.1 LabCorp (US) Company Detail
11.7.2 LabCorp (US) Business Overview
11.7.3 LabCorp (US) Specimen Validity Testing Introduction
11.7.4 LabCorp (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.7.5 LabCorp (US) Recent Development
11.8 Quest Diagnostics (US)
11.8.1 Quest Diagnostics (US) Company Detail
11.8.2 Quest Diagnostics (US) Business Overview
11.8.3 Quest Diagnostics (US) Specimen Validity Testing Introduction
11.8.4 Quest Diagnostics (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.8.5 Quest Diagnostics (US) Recent Development
11.9 Alere Toxicology (US)
11.9.1 Alere Toxicology (US) Company Detail
11.9.2 Alere Toxicology (US) Business Overview
11.9.3 Alere Toxicology (US) Specimen Validity Testing Introduction
11.9.4 Alere Toxicology (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.9.5 Alere Toxicology (US) Recent Development
11.10 ACM Global Laboratories (US)
11.10.1 ACM Global Laboratories (US) Company Detail
11.10.2 ACM Global Laboratories (US) Business Overview
11.10.3 ACM Global Laboratories (US) Specimen Validity Testing Introduction
11.10.4 ACM Global Laboratories (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.10.5 ACM Global Laboratories (US) Recent Development
11.11 Clinical Reference Laboratory (CRL) (US)
11.11.1 Clinical Reference Laboratory (CRL) (US) Company Detail
11.11.2 Clinical Reference Laboratory (CRL) (US) Business Overview
11.11.3 Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Introduction
11.11.4 Clinical Reference Laboratory (CRL) (US) Revenue in Specimen Validity Testing Business (2017-2022)
11.11.5 Clinical Reference Laboratory (CRL) (US) Recent Development
11.12 SureHire (Canada)
11.12.1 SureHire (Canada) Company Detail
11.12.2 SureHire (Canada) Business Overview
11.12.3 SureHire (Canada) Specimen Validity Testing Introduction
11.12.4 SureHire (Canada) Revenue in Specimen Validity Testing Business (2017-2022)
11.12.5 SureHire (Canada) Recent Development
11.13 CannAmm (Canada)
11.13.1 CannAmm (Canada) Company Detail
11.13.2 CannAmm (Canada) Business Overview
11.13.3 CannAmm (Canada) Specimen Validity Testing Introduction
11.13.4 CannAmm (Canada) Revenue in Specimen Validity Testing Business (2017-2022)
11.13.5 CannAmm (Canada) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
